Wuhan Keqian Biology Co Ltd Capital Reinvestment Ratio
Wuhan Keqian Biology Co Ltd capital reinvestment ratio. Wuhan Keqian Biology Co Ltd (688526) has a Capital Reinvestment Ratio of 0.07x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥174.36 Million) in capital expenditures (CN¥11.35 Million). Check Wuhan Keqian Biology Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Wuhan Keqian Biology Co Ltd (2016–2024)
Capital reinvestment ratio of Wuhan Keqian Biology Co Ltd from 2016 to 2024. This chart tracks Wuhan Keqian Biology Co Ltd's Capital Reinvestment Ratio across 9 annual periods. Also explore Wuhan Keqian Biology Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Wuhan Keqian Biology Co Ltd Capital Reinvestment Ratio by Year (2016–2024)
Wuhan Keqian Biology Co Ltd capital reinvestment ratio by year from 2016 to 2024. For the full cash flow conversion analysis, see 688526 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.27x | CN¥392.68 Million | CN¥106.94 Million | ▲ +40.2% |
| 2023 | 0.19x | CN¥538.03 Million | CN¥104.50 Million | ▼ -20.0% |
| 2022 | 0.24x | CN¥423.71 Million | CN¥102.85 Million | ▼ -65.6% |
| 2021 | 0.70x | CN¥531.27 Million | CN¥374.45 Million | ▲ +152.7% |
| 2020 | 0.28x | CN¥400.14 Million | CN¥111.60 Million | ▼ -68.6% |
| 2019 | 0.89x | CN¥154.89 Million | CN¥137.74 Million | ▲ +895.7% |
| 2018 | 0.09x | CN¥351.83 Million | CN¥31.42 Million | ▼ -76.6% |
| 2017 | 0.38x | CN¥337.61 Million | CN¥129.11 Million | ▲ +189.7% |
| 2016 | 0.13x | CN¥220.69 Million | CN¥29.13 Million | — |